Semaglutide

Semaglutide is a novel GLP-1 receptor agonist peptide designed to target key receptors involved in metabolic regulation. Research has shown that Semaglutide supports significant improvements in glucose control, promotes weight loss, and enhances insulin sensitivity. It acts by mimicking and activating the GLP-1 gut hormone to regulate appetite, energy expenditure, and metabolic function. This peptide is being explored for its potential in treating metabolic disorders such as type 2 diabetes and obesity. Its targeted GLP-1 mechanism offers a promising approach to comprehensive metabolic health management.

STRICTLY FOR LABORATORY RESEARCH USE ONLY.

Purity >99%

Peptides will arrive in a lyophilized (powder) form for maximum stability